|Articles|October 1, 2013
- BioPharm International-10-01-2013
- Volume 26
- Issue 10
BioPharm International, October 2013 Issue (PDF)
Click the title above to open the BioPharm International October 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 12 years ago
Navigating Emerging Markets: Middle East and North Africaover 12 years ago
The Expense of Vision in Outsourcingover 12 years ago
Increasing Capacity Utilization in Protein A Chromatographyover 12 years ago
Changing the Dynamic of CROsover 12 years ago
FDA Seeks Metrics to Define Drug Qualityover 12 years ago
Angiopoietins: Novel Targets for Anti-angiogenesis Therapyover 12 years ago
Report from Myanmarover 12 years ago
Operational Excellence: More Than Just Process Improvementover 12 years ago
Robust IPO Market for Life Sciences Sparks Change Among Investorsover 12 years ago
Performing a Protein Purity Analysis Comparability StudyNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
3
Executive Summary: From Molecule to Formulation: A Systematic Approach to Assess Biologics Developability
4
Novartis Calls for Global Governments to Address Global Trade Policy
5
